Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 6Brain Neoplasms 4Oligodendroglioma 3Lymphoma, Follicular 3Gliosarcoma 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Optic Nerve Glioma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Central Nervous System Neoplasms 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Sezary Syndrome 1Renal Insufficiency 1Recurrence 1Primary Myelofibrosis 1

Interventions

Temozolomide 10Filgrastim 7Peripheral Blood Stem Cell Transplantation 5Carboplatin 5O(6)-benzylguanine 3Etoposide 3Donepezil 3Cyclophosphamide 3Vorinostat 2Vincristine 2Psychiatric Rehabilitation 2Paclitaxel 2Irinotecan 2Granulocyte Colony-Stimulating Factor 2Cisplatin 2Carmustine 2Bortezomib 2veliparib 1temsirolimus 1sargramostim 1romidepsin 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1exatecan 1etoposide phosphate 1entinostat 1carboxyamido-triazole 1becatecarin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Choroid Plexus Neoplasms × Cilengitide × Clear all
NCT00063973 2013-09-30

Cilengitide in Treating Children With Refractory Primary Brain Tumors

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Choroid Plexus Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡